Baxter - BAX Enterprise Value-to-Revenue Multiple

baxter.com (BAX) - corporate logo

The EV/Sales ratio formed by GURU.Markets quotes is constrained by strict FDA oversight and long-term contracts with clinics. The value 1648.91 indicates the current valuation of the business relative to revenue. The stable income of Baxter International (BAX) is based on the sale of dialysis systems and infusion solutions. Its status as an indispensable supplier of critical equipment ensures perpetual demand for the company.

BAX: Baxter International Inc. Company Value to Revenue 11/23/2025 - 11/20/2026

Baxter Corp - analytical breakdowns and key metrics (BAX)

- market value and analyst target forecast:
Fundamental company valuation:BAX - Baxter
Original product of Baxter International Inc.

This indicator determines the market value of the entire business, including debt, per unit of revenue, excluding the impact of the credit structure. By analyzing the Enterprise Value to revenue ratio, an investor assesses the fundamental attractiveness of the asset regardless of its financing methods. For Baxter International (BAX), this metric is critical when optimizing the renal segment and managing a high debt load against a backdrop of stable sales.

Direct competitors

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Enterprise Value-to-Revenue Ratio Masimo (MASI)|Stevanato Group - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio Teleflex Inc. TFX|Enterprise Value-to-Revenue Coefficient MMSI (Merit Medical Systems, Inc.)|NVST - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio ICU Medical Corp ICUI|XRAY: EV/Sales Multiple|LMAT (LeMaitre Vascular, Inc.) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue ATRC|STAA (STAAR Surgical) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ChromaDex (NAGE)|Company Value to Revenue ZimVie Inc. ZIMV|EV/Sales Multiple ANGO (angiodynamics.com)|EV/Sales Multiple cerus.com CERS|teknova.com - EV/Sales Multiple|Enterprise Value-to-Sales Ratio Monogram Technologies Inc. (MGRM)|Sharps Technology, Inc. (STSS) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Multiple InfuSystem Inc (INFU)|UTMD (Utah Medical Products Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple KORU Medical Systems KRMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple